Tough to treat tumors in elderly patients: A 12-year review of sarcoma cases at Hôpital René Huguenin/Institut Curie

treatment before the development of TEE. 44% of the geriatric patients were treated with lifelong anticoagulation compared with 62.5% for the younger cohort. Surgery, chemotherapy and presence of DVT were significant risk factors for the development of TEE (Pb0.05). Conclusion: Geriatric oncology patients who develop TEE have a different clinical profile compared with the younger cohort of patients. Majority of them develop TEE as an outpatient. A high index of suspicion for TEE is required in this setting.